Bill > HR6089

This bill establishes a National Biopharmaceutical Manufacturing Center of Excellence to advance biotechnology capabilities in the United States. The center will be managed by the National Institute of Standards and Technology (NIST) and will focus on developing innovative biopharmaceutical manufacturing technologies, particularly for products critical to national security, health, and economic interests. The center will support research and development, improve manufacturing processes, reduce supply chain bottlenecks, and promote workforce training in biotechnology. Eligible entities like public-private partnerships, higher education institutions, or consortia can apply for a competitive grant of up to $120 million in fiscal year 2026. The center's objectives include advancing biomanufacturing science, supporting good manufacturing practices, developing infrastructure, and collaborating with various stakeholders such as universities, pharmaceutical manufacturers, government agencies, and nonprofits. The bill recognizes that biotechnology has transformative potential in areas like medicine, agriculture, and military capabilities, and aims to position the United States as a leader in developing and implementing these technologies. The center will be required to submit annual reports to Congress detailing its progress, activities, and findings, and will also establish intellectual property guidelines for its research.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/6089/all-info